Yahoo Finance • 4 days ago
Key Takeaways; Cannabis Sector Organigram Secured C$65.2 Million Strategic Investment from British American Tobacco After the Company Agreed to Acquire Sanity Group Canopy Growth Secured Shareholder Backing for MTL Cannabis Acquisition Gr... Full story
Yahoo Finance • 7 days ago
This article first appeared on GuruFocus. Cathie Wood's ARK Invest added to Figma (NYSE:FIG) and trimmed DraftKings (NASDAQ:DKNG) on Feb. 19, as part of a broader portfolio reshuffle. ARK funds bought about $24 million of Figma shares af... Full story
Yahoo Finance • 10 days ago
It's been a long road for Compass Pathways(NASDAQ: CMPS) to prove that its treatment using psilocybin therapy for treatment-resistant depression (TRD) can be successful. It was back in 2018 when the company received breakthrough therapy de... Full story
Yahoo Finance • 10 days ago
[Technical Price Chart Data Analysis Showing 2020 Corona Virus Covid-19 Stock Market Crash] Stock futures dipped Tuesday morning amid a holiday-shortened trading week, spotlighting key economic data and corporate earnings ahead. Here are... Full story
Yahoo Finance • 4 months ago
[Magic Mushroom stock images] Betka82/iStock via Getty Images Companies focused on psychedelic medicines traded higher on Tuesday after Marijuana Moment reported Bob Brinson, a Republican state senator in North Carolina, as saying that hi... Full story
Yahoo Finance • 6 months ago
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of ind... Full story
Yahoo Finance • 7 months ago
Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story
Yahoo Finance • 7 months ago
H.C. Wainwright lowered the firm’s price target on Compass Pathways (CMPS) to $40 from $45 and keeps a Buy rating on the shares. Compass confirmed that no further development is planned in anorexia nervosa following completion of the Phase... Full story
Yahoo Finance • 7 months ago
Cathie Wood’s ARK ETFs have made significant moves in the stock market on Friday, August 1, 2025, with a particular focus on tech and biotech companies. Leading the trades was a massive purchase of Coinbase Global Inc (NASDAQ:COIN) share... Full story
Yahoo Finance • 7 months ago
* COMPASS Pathways ADS (NASDAQ:CMPS [https://seekingalpha.com/symbol/CMPS]) is scheduled to announce Q2 earnings results on Thursday, July 31st, before market open. * The consensus EPS Estimate is -$0.37 [https://seekingalpha.com/symbo... Full story
Yahoo Finance • 8 months ago
Cathie Wood’s ARK ETFs disclosed their daily trades for Wednesday, July 9th, 2025, with a significant focus on the tech and healthcare sectors. In the largest transaction of the day, ARK increased its position in Tempus AI Inc (NYSE:TEM),... Full story
Yahoo Finance • 8 months ago
Cathie Wood’s ARK ETFs disclosed their daily trades for Thursday, 3rd July 2025, with a mix of buys and sells across various sectors. The most significant trade of the day involved the sale of KOMATSU LTD (TYO:6301) shares, with ARKX (NYSE... Full story
Yahoo Finance • 8 months ago
Cathie Wood’s ARK ETFs have reported their daily trades for Wednesday, July 2nd, 2025, showcasing a mix of aggressive buys and strategic sells that may signal the firm’s shifting investment focus. The largest transaction of the day involve... Full story
Yahoo Finance • 8 months ago
Cathie Wood’s ARK ETFs have made their latest round of daily trades on Tuesday, 01 July 2025, with significant activity across a variety of sectors. In a notable move, ARK has increased its holdings in Tesla Inc (NASDAQ:TSLA) with a substa... Full story
Yahoo Finance • 8 months ago
PALM BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a rising demand for neuropsychiatric disorder treatments which is expected to fuel the global markets for years to come. With expand... Full story
Yahoo Finance • 8 months ago
Investing.com - H.C. Wainwright maintained its Buy rating and $45.00 price target on Compass Pathways (NASDAQ:CMPS) following breakthrough clinical trial results for its psilocybin therapy. The global treatment-resistant depression market... Full story
Yahoo Finance • 8 months ago
Investing.com - BTIG lowered its price target on Compass Pathways (NASDAQ:CMPS) to $7.00 from $12.00 on Tuesday while maintaining a Buy rating, citing concerns about the company’s COMP360 drug development. For deeper insights into CMPS’s f... Full story
Yahoo Finance • 8 months ago
Monday’s market has seen significant movements across various stocks, with companies like Tesla Motors (NASDAQ:TSLA) and Regencell Bioscience Holdings (RGC) experiencing notable changes. These intra-day stock movements are driven by a mi... Full story
Yahoo Finance • 8 months ago
[Microdosing concept.Dried psilocybin mushrooms Golden Teacher.Psychedelic Psilocybe Cubensis mushrooms. Medical use.Microdosing.] IURII BUKHTA/iStock via Getty Images Compass Pathways (NASDAQ:CMPS [https://seekingalpha.com/symbol/CMPS])... Full story
Yahoo Finance • 8 months ago
Monday’s market has seen notable fluctuations among various stocks, particularly within the mega-cap and large-cap categories. Tesla Motors (NASDAQ:TSLA) and Advanced Micro Devices (NASDAQ:AMD) are experiencing significant rallies, while... Full story